Survey: Most Patient Comfortable With Telehealth, Some Providers Worried About the Viability of Their Organization

Article

A survey by Luma Health shows that 52% of patients are comfortable or very comfortable with telehealth. A quarter of providers see a risk of their organizations going out of business.

Designating a separate entrance and treatment area for COVID-19 patients and enforcing social distancing in lobbies and waiting areas are among the steps that hospital executives could take to make patients less worried about COVID-19 exposure, according to the results of a survey conducted by Luma Health.

Luma Health is San Francisco-based digital health company that markets patient-provider communication and marketing tools.

In an online survey completed by 1,293 patients in August and September, 64% of the respondents indicated that a separate entrance and area could make them feel less worried about COVID-19 exposure and 57% said enforcing social distancing in lobbies would help ease those concerns.

Offering curbside care and “zero contact check-in” was favored by 40% of the respondents, and 53% said they would be interested in a curbside blood pressure check,

The company's survey included many questions telehealth and the answers were in keeping the prevailing thinking that patients and providers have responded well to the pivot into remote care and that telehealth has become a permanent part of the healthcare system. The results show that a slim majority (52%) of patients were comfortable or extremely comfortable with telehealth. A larger proportion (66%) indicated that they were satisfied with their telehealth experience.

The company also surveyed 165 healthcare providers. More than 60% of the providers indicated that they believe patients will experience illness that could have been avoided because of diverted or avoided care, and 38% expect non-COVID-19 deaths to occur because of care delay.

The survey reveals some providers are concerned about the future viability of their organizations. About a third of the providers indicated that their organizations are operating below 60% capacity, and roughly a quarter see a risk of their organization closing in a year or less if COVID-19 continues to disrupt care and cause revenue losses.

Recent Videos
Jill Zouzoulas, MD, FACR, an expert on biologic therapies
Lawrence Eichenfield, MD, an expert on atopic dermatitis
Video 5 - "Obstacles in Adapting Diabetes Technology to Individual Needs" - 1 KOL is featured
Lawrence Eichenfield, MD, an expert on atopic dermatitis
Lawrence Eichenfield, MD, an expert on atopic dermatitis
Video 4 - "The Impact of Continuous Glucose Monitors & Digital Solutions on Diabetes Care"
Video 3 - "The Pivotal Role of Patient Engagement and Education in Achieving Optimal Diabetes Outcomes"
Related Content
© 2024 MJH Life Sciences

All rights reserved.